Benefibre, Orange Creme Chewables, 36ct and 100ct chewable tablet bottles. Foreign labeling:…
Recalling firm: Novartis Consumer Health
The lot number and/or expiration date may be illegible on the outer plastic bottle packaging.
Historical recall record. This is not a new recall announcement. “Terminated” describes the FDA recall process; it does not certify that an individual package is safe. FDA termination date: Nov 4, 2014.
Check your package
Compare the exact product and package details with the label you have.
FDA code information
Lot Number and Expiration date 36ct bottle: 10101294, 12/31/2013; 10114155, 4/30/2014 100ct bottle: 10097346,8/31/2013;10104669,12/31/2013;10117018,1/31/2014;10117019, 4/30/2014;10120625,8/31/2014.
Match the product, package size, and code together. A missing match does not guarantee safety.
Full FDA record and distribution details
Original product description
Benefibre, Orange Creme Chewables, 36ct and 100ct chewable tablet bottles. Foreign labeling: Novartis Consumer Health Canada Inc, Mississauga, ON.
Original FDA recall reason
The lot number and/or expiration date may be illegible on the outer plastic bottle packaging.
Recall details
- Recall number
- F-1907-2013
- Event ID
- 66013
- FDA status
- Terminated
- Initiated
- Aug 6, 2013
- Reported
- Sep 25, 2013
- Classified
- Sep 19, 2013
- Terminated
- Nov 4, 2014
- Quantity
- 70,380 units
- Location
- Lincoln, NE, United States
- Initiation type
- Voluntary: Firm initiated
- Notification
- Letter
Where it was distributed
Distribution was made nationwide.
Data updated September 16, 2026. View official FDA data ↗
Follow official FDA and manufacturer guidance.